Resveratrol protects against hepatic insulin resistance in a rat's model of non-alcoholic fatty liver disease by down-regulation of GPAT-1 and DGAT2 expression and inhibition of PKC membranous translocation.
This article is protected by copyright. All rights reserved.
PMID: 30773673 [PubMed - as supplied by publisher]
Source: Physiological Research - Category: Physiology Authors: Badi RM, Mostafa DG, Khaleel EF, Satti HH Tags: Clin Exp Pharmacol Physiol Source Type: research
More News: Alcoholism | Diets | Fatty Liver Disease (FLD) | High Fat | Insulin | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Nutrition | Physiology | Study | Translocation | Urology & Nephrology